Structures by: Khan A. H.
Total: 8
C17H11NO3S2
C17H11NO3S2
Organic & biomolecular chemistry (2020) 18, 21 4104-4113
a=6.4978(4)Å b=14.5164(14)Å c=16.2262(14)Å
α=90° β=90° γ=90°
C17H11NOS2
C17H11NOS2
Organic & biomolecular chemistry (2020) 18, 21 4104-4113
a=17.5086(10)Å b=11.7781(8)Å c=13.9721(9)Å
α=90° β=92.715(6)° γ=90°
3-{(<i>E</i>)-[(3,4-Dichlorophenyl)imino]methyl}benzene-1,2-diol
C13H9Cl2NO2
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 2 o137
a=6.4237(8)Å b=8.8412(11)Å c=11.7799(15)Å
α=88.606(6)° β=76.588(6)° γ=70.193(5)°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>'-(2- thienylmethylidene)acetohydrazide
C18H17N5O3S2
Acta Crystallographica Section E (2010) 66, 6 o1265-o1266
a=18.5474(2)Å b=11.6670(5)Å c=8.4783(7)Å
α=90.00° β=90.00° γ=90.00°
4-{[(<i>E</i>)-2,3-Dihydroxybenzylidene]amino}- <i>N</i>-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
C17H15N3O5S
Acta Crystallographica Section E (2012) 68, 7 o2125
a=7.1881(6)Å b=10.6682(10)Å c=11.6865(9)Å
α=92.181(4)° β=99.776(4)° γ=99.606(5)°
2-[(<i>E</i>)-({4-[(4,6-Dimethylpyrimidin-2-yl)sulfamoyl]phenyl}iminio)methyl]- 6-hydroxyphenolate
C19H18N4O4S
Acta Crystallographica Section E (2012) 68, 9 o2687
a=24.7506(12)Å b=12.1689(6)Å c=12.8408(5)Å
α=90° β=90° γ=90°
4-Bromo-2-{(<i>E</i>)-[(3,4-dimethylphenyl)imino]methyl}phenol
C15H14BrNO
Acta Crystallographica Section E (2012) 68, 9 o2730
a=12.2633(10)Å b=7.4805(6)Å c=14.5767(11)Å
α=90° β=101.576(4)° γ=90°
(<i>E</i>)-2-[(4-hydroxybenzylidene)azaniumyl]benzoate
C14H11NO3
Acta Crystallographica Section E (2014) 70, 9 o1008
a=3.8612(5)Å b=15.280(3)Å c=18.604(3)Å
α=90° β=90.347(8)° γ=90°